Dole plc to Participate in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit
Dole plc to Participate in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit
Dole plc (NYSE: DOLE) (“Dole” or the “Company”) a global leader in fresh produce, today announced that management will be participating in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit, to be held at the Westin New York Grand Central in New York, NY on September 17, 2024.
At 09.30 a.m. ET on September 17, the Company will participate in a fireside chat with TD Cowen analyst Robert Moskow and will also participate in one-on-one meetings with investors at the conference.
The live webcast and a replay after the event can be accessed at https://www.doleplc.com/investor-relations/events-and-presentations/ or directly at https://wsw.com/webcast/cowen166/dole/2004324.
About Dole plc:
A global leader in fresh produce, Dole Plc grows, markets, and distributes an extensive variety of fresh fruits and vegetables sourced locally and from around the world. Dedicated and passionate in exceeding our customers’ requirements in over 75 countries, our goal is to make the world a healthier and a more sustainable place.
Category: Financial
Investor Contact:
James O’Regan, Head of Investor Relations, Dole plc
investors@doleplc.com
+353 1 887 2794
View source version on businesswire.com: https://www.businesswire.com/news/home/20240829921745/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks